JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2002; 40:499-504
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flevari, P.
Right arrow Articles by Kremastinos, D. T. h
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flevari, P.
Right arrow Articles by Kremastinos, D. T. h

Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients’ well-being

Panagiota Flevari, MD*,*, Efthimios G. Livanis, MD*, George N. Theodorakis, MD*, Elias Zarvalis, MD*, Theoni Mesiskli, MD* and Dimitrios T. h Kremastinos, MD*

* Second Department of Cardiology, Onassis Cardiac Surgery Center, Athens, Greece



View larger version (9K):

[in a new window]
  		Figure 1 Mean (±SE) number of syncopal episodes before and during therapy with propranolol, nadolol and placebo.

 


View larger version (9K):

[in a new window]
  		Figure 2 Mean (±SE) number of presyncopal episodes before and during therapy with propranolol, nadolol and placebo.

 


View larger version (13K):

[in a new window]
  		Figure 3 Patients’ self-assessed well-being before and during therapy with propranolol, nadolol and placebo.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2002 by the American College of Cardiology Foundation.